4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-24-002286
Options or other derivatives
- Chief Financial Officer acquired 80,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Downs Christopher · Chief Financial Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-04-08 | Grant or award : show line 1 in the form Option to purchase common stock | +40,000 | 201.57 | D |
| 2024-04-08 | Grant or award : show line 2 in the form Restricted Stock Units | +40,000 | 241.57 | D |
Loading xslF345X05/ownership.xml…